Cytidine-5-diphosphocholine supplement in early life induces stable increase in dendritic complexity of neurons in the somatosensory cortex of adult rats  by Rema, V. et al.
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0
dYTIDINE-5-DIPHOSPHOCHOLINE SUPPLEMENT IN EARLY LIFE
NDUCES STABLE INCREASE IN DENDRITIC COMPLEXITY OF
EURONS IN THE SOMATOSENSORY CORTEX OF ADULT RATS
c
t
C
t
w
C
p
a
e
r
f
t
U
b
(
i
c
d
i
t
s
n
t
n
J
2
s
(
t
d
s
t
c
N
c
b
C
d
T
p
c
A
p
a. REMA,* K. K. BALI, R. RAMACHANDRA, M. CHUGH,
. DAROKHAN AND R. CHAUDHARY
ational Brain Research Centre, NH-8, Nainwal Mode, Manesar,
aryana-122050, India
bstract—Cytidine-5-diphosphocholine (CDP-choline or citi-
holine) is an essential molecule that is required for biosyn-
hesis of cell membranes. In adult humans it is used as a
emory-enhancing drug for treatment of age-related demen-
ia and cerebrovascular conditions. However the effect of
DP-choline on perinatal brain is not known. We adminis-
ered CDP-choline to Long Evans rats each day from concep-
ion (maternal ingestion) to postnatal day 60 (P60). Pyramidal
eurons from supragranular layers 2/3, granular layer 4 and
nfragranular layer 5 of somatosensory cortex were examined
ith Golgi–Cox staining at P240. CDP-choline treatment sig-
ificantly increased length and branch points of apical and
asal dendrites. Sholl analysis shows that the complexity of
pical and basal dendrites of neurons is maximal in layers 2/3
nd layer 5. In layer 4 significant increases were seen in
asilar dendritic arborization. CDP-choline did not increase
he number of primary basal dendrites on neurons in the
omatosensory cortex. Primary cultures from somatosen-
ory cortex were treated with CDP-choline to test its effect on
euronal survival. CDP-choline treatment neither enhanced
he survival of neurons in culture nor increased the number
f neurites. However significant increases in neurite length,
ranch points and total area occupied by the neurons were
bserved. We conclude that exogenous supplementation of
DP-choline during development causes stable changes
n neuronal morphology. Significant increase in dendritic
rowth and branching of pyramidal neurons from the so-
atosensory cortex resulted in enlarging the surface area
ccupied by the neurons which we speculate will augment
rocessing of sensory information. © 2008 IBRO. Published
y Elsevier Ltd. 
ey words: citicholine, barrel cortex, Golgi–Cox, stroke, plas-
icity, Sholl analysis.
ytidine-5-diphosphocholine (CDP-choline) is being used
s a neuroprotective and memory enhancing drug in con-
itions such as aging (Alvarez et al., 1997; Teather and
urtman, 2003) and other neurovascular diseases (see
eview by Adibhatla and Hatcher, 2005). Its role as a
rucial intermediate in the biosynthesis of cell membrane
hospholipids is well established (Kennedy and Weiss,
956). Orally administered CDP-choline is hydrolyzed to
Corresponding author. Tel: 91-124-2338922; fax:91-124-2338928.
-mail address: rema@nbrc.ac.in (V. Rema).
bbreviations: CDP-choline, cytidine-5-diphosphocholine; DAPI, 4=,6-
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iamidino-2-phenylindole; DMEM, Dulbecco’s minimal essential me-
ium; MAP2, microtubule-associated protein 2; P, postnatal day.
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Open access under CC BY licenseholine and cytidine (Agut et al., 1993) and subsequently
aken up from the blood by brain and other tissues (Lopez-
oviella et al., 1995). In the brain choline gets metabolized
o phosphorylcholine (Millington and Wurtman, 1982)
hich then combines with CTP to generate intracellular
DP-choline which is subsequently converted to phos-
hatidylcholine (Adibhatla et al., 2004). Choline in the brain
lso gets converted to acetylcholine especially in cholin-
rgic neurons (Blusztajn and Wurtman, 1983). If there is
eduction in acetylcholine levels in the brain then choline
rom neuronal membrane phosphatidylcholine is used for
he synthesis of acetylcholine (Maire and Wurtman, 1985;
lus et al., 1989).
Injuries such as middle cerebral artery occlusion have
een shown to cause reduction in phosphatidylcholine
Adibhatla et al., 2006). Since phosphatidylcholine is an
ntegral component of cell membranes any change in its
oncentration would affect membrane stability and cause
amage to the cell which could result in neurological def-
cits. In an experimental model of stroke in adult rats Hur-
ado et al. (2007) have seen increase in branch orders and
pine numbers on basilar dendrites of layer V pyramidal
eurons from motor cortex following chronic CDP-choline
reatment. Although stroke is known to occur during preg-
ancy (Mas and Lamy, 1998; Sloan and Stern, 2003;
aigobin and Silver, 2000) and at perinatal ages (Nelson,
007) the effect of treatment with CDP-choline on neuronal
tructure of the developing brain is not known.
We therefore addressed two questions in this study
1) Does exogenously supplemented CDP-choline during
he developmental period of the brain produce changes in
endritic arborization of neurons? (2) Are these changes
table? We administered CDP-choline throughout gesta-
ion up to postnatal day (P) 60. This time period was
hosen because it encompassed the temporal changes in
MDAR1 expression that occurs in the somatosensory
ortex from early development until attaining adult levels
y P60 (Rema and Ebner, 1996). Our results show that
DP-choline treatment increases the complexity of den-
ritic arborization and this effect is sustained long term.
he consequence of this enhanced dendritic complexity
otentially increases the total synaptic contact area and
ould facilitate processing within a neural network.
EXPERIMENTAL PROCEDURES
ll experimental procedures carried out for this study were ap-
roved by the NBRC Institutional Animal Ethical Care Committee
nd followed NIH guidelines. Long Evans rats used for this study
ere on 12-h light/dark cycle with free access to food and water
.
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V. Rema et al. / Neuroscience 155 (2008) 556–564 557nd housed in temperature-controlled room (25 °C). In each cage
ne female rat and one male rat were placed for mating. To
nsure that there was no social isolation the females were sepa-
ated from their mates only during last week of gestation. The pups
ere weaned from their mother on P21 and two pups of the same
ex were housed in each cage until they were adults. The number of
nimals used for this study was the minimum required, and care was
aken to minimize their suffering.
DP-choline administration
xperimental group consisted of pups born to female animals that
ere administered CDP-choline (Sigma-Aldrich, St. Louis, MO,
SA) at a concentration of 100 mg/kg orally once a day in the
orning. We used this concentration based on the studies by Agut
t al. (1984) which showed that a dose of 100 mg/kg body weight
f CDP-choline administrated orally was neuroprotective in rats. A
tock solution of the drug was made in water each day. From the
rst day of gestation the pregnant dams were weighed daily and
he required amount of CDP-choline solution applied on two
ieces of cornflakes was fed to the rats. After birth from P1 up to
14 (P0 is day of birth) CDP-choline was administered to the pups
n liquid form. The pups were weighed and the required amount of
DP-choline solution was aliquoted directly into the mouth using
micropipette. From P14 till P60 CDP-choline was given to the
ups with cornflakes as described above. Control group consisted
f animals treated in similar manner as experimental animals
xcept that water was used instead of CDP-choline. Morphologi-
al analyses of neurons from somatosensory cortex were done 6
onths later by Golgi–Cox staining of neurons.
olgi–Cox staining
rains from 11 male rats aged P240 which included five controls
nd six CDP-choline-treated (one from each litter) were used for
olgi–Cox staining. Animals were deeply anesthetized and per-
used transcardially with normal saline (0.9% NaCl). The brains
ere removed and cut into three blocks and immersed in Golgi–
ox solution (Glaser and van der Loos, 1981) for 14 days in the
ark during which time the Golgi–Cox solution was changed every
days. The brains were then sunk in 30% sucrose solution,
ectioned at 200 m thickness on a vibratome and processed for
olgi–Cox staining as described by Gibb and Kolb (1998).
at primary cortical cultures
ortical cultures were established from somatosensory cortex of
ormal P0 Long Evans pups following modified procedure of
almer et al. (1999). The tissue was minced and incubated in a
olution containing papain (2.5 U/ml, Sigma-Aldrich) and DNAse
250 U, Sigma-Aldrich) for 5 min at 37 °C and cells were dissoci-
ted by gentle pipetting in Dulbecco’s minimal essential medium
DMEM). After washing the cells three times in DMEM they were
uspended in plating medium containing DMEM, L-glutamine,
27, N2 and penicillin/streptomycin 100 U/ml (all media compo-
ents were from Gibco, Invitrogen Corporation, Carlsbad, CA,
SA). Cells were plated onto polylysine-D-lysine (Sigma-Aldrich)
nd laminin (Sigma-Aldrich) precoated glass coverslips at a den-
ity of 105 cells per coverslip in 12 well Nunc plate and cultured at
7 °C and 5% CO2. At 6 h following plating (after the cells had
ttached to the substrate) the medium was replaced with fresh
edium. CDP-choline (Sigma-Aldrich) treatment began from the
econd day in culture. For the treatment the medium was changed
nd replaced with medium containing 50 M or 100 M CDP-
holine every alternate day. Control cultures were not treated with
DP-choline. The cultures were maintained for 15 days and then
xed with 4% paraformaldehyde. Four sets of cultures (each set
onsisting of one control, one 50 MCDP-choline-treated and one
00 M CDP-choline-treated coverslip) were prepared for one Cxperiment. The experiment was repeated thrice. The cultures
ere immunoreacted with antibodies to microtubule-associated
rotein 2 (MAP2) to visualize the neurons using the method de-
cribed in Rema and Ebner (1999). The coverslips were mounted
n slides with mounting media containing 4=,6-diamidino-2-phe-
ylindole (DAPI) (Vector Laboratories, Burlingame, CA, USA) to
tain all the nuclei.
euronal tracing and data analysis
yramidal neurons from the layers 2/3, layer 4 and layer 5 of so-
atosensory cortex with complete cellular and dendritic staining
ere selected for analysis. These neurons had a prominent apical
endrite pointing toward the pial surface. Digital reconstruction of
he neurons was done in 3-D using Neurolucida (MicroBrightField,
olchester, VT, USA) and Microfire camera attached to a Nikon
clipse E800 microscope. We used Golgi–Cox staining technique
ecause with this technique visualization of more neurons from all
ayers of the cortex was easily possible.
The morphological parameters measured for each neuron
ere (i) total apical dendritic length, (ii) total basilar dendritic
ength, (iii) branch order, (iv) total number of branch points
nodes), and (v) total area occupied by the cell body and its
endrites determined using convex hull analysis. These features
f neurons were determined from the reconstructed neuronal data
nd quantitative analysis was done using Neuroexplorer software
MicroBrightField). The complexity of dendritic arborization was
btained from Sholl analysis by calculating the number of dendritic
ranches that intersect defined concentric circles spaced 25 m
part starting from the center of cell body as a function of distance
rom soma.
euron and total cell counts
he effect of CDP-choline treatment on neuronal and total cell
urvival was determined from the primary cultures of somatosen-
ory cortex. Neurolucida software was used to count the cells from
he serial images that were taken of the entire culture area from
ach condition. For determining the total cell counts DAPI-stained
uclei were counted. The values obtained for control condition
as taken as 100% and used as reference to determine changes
n the experimental conditions. For estimating the number of neu-
ons, MAP2-labeled cells were counted to calculate the percent of
eurons with respect to the total cells in each coverslip. Neuronal
orphology of cultured neurons was determined by tracing and
nalyzing five neurons, from each dish, using Neurolucida soft-
are. From each condition 40 neurons were traced and analyzed
sing the methods similar to those used for the in vivo experi-
ents as described above.
tatistical analysis
rom each animal three to five neurons were traced from each
ayer. The values of all neurons from each layer were averaged for
ach individual animal. This mean value was taken as the unit of
nalysis. Statistical tests were performed using repeated mea-
ures analyses of variance (ANOVA) to compare experimental
nd control groups. The level of significance between control and
xperimental conditions was taken at P0.05. All statistical tests
ere performed using SigmaStat.
RESULTS
nimals were weighed every day for the initial 2 months
nd twice a week for the rest of the experiment. Their
ehavior in standard home cages was also visually moni-
ored. We did not find differences in the weight or behavior
n their home cages between the control group and the
DP-choline administered group.
v
s
r
i
p
r
t
b
a
o
l
t
m
t
p
d
E
m
C
i
a
d
a
b
m
(
o
m
d
d
e
f
e
g
d
f
(
r
b
t
(
l
i
b
E
A
t
d
i
b
e
(
t
F
c
c
F
d
V. Rema et al. / Neuroscience 155 (2008) 556–564558In this study we used Golgi–Cox staining technique to
isualize neurons from layers 2/3, layer 4 and layer 5 of
omatosensory cortex of CDP-choline-treated and control
ats brains because this technique robustly labeled a lim-
ted number of neurons throughout the cortex. Fig. 1 shows
hotomicrograph of the Golgi–Cox stained pyramidal neu-
ons from the somatosensory cortex of a CDP-choline-
reated rat. Neurons with complete impregnation of cell
ody and dendrites which were unobstructed by other cells
nd dendrites were selected for tracing and reconstruction
f the entire dendritic tree. All analyzed neurons from all
ayers had a prominent apical dendrite which projected
oward the pial surface.
To determine the effect of CDP-choline on the dendritic
orphology we traced the neurons from CDP-choline-
reated animals and controls (Fig. 2). We compared com-
lexity in arborization of apical dendrites and basal den-
rites for neurons from each layer.
ig. 1. Photomicrograph of pyramidal neurons from somatosensory
ortex of a CDP-choline-treated rat showing complete impregnation of
ell body and dendrites stained with the Golgi–Cox method.ig. 2. Neurolucida tracings of pyramidal neurons from somatosensory cortex
endritic arborization after CDP-choline treatment (scale bar100m).ffect of CDP-choline on apical dendritic
orphology
omparison of arborization of apical dendrites of neurons
n the somatosensory cortex between CDP-choline-treated
nd control animals is shown in Fig. 3. The total apical
endritic length (which included the length of the primary
pical dendrite and the length of all apical dendritic
ranches) in CDP-choline-treated rats was significantly
ore in neurons within layers 2/3 (P0.006) and layer 5
P0.02) (Fig. 3A). However apical dendritic morphology
f layer 4 neurons was not affected by CDP-choline treat-
ent. The complexity of apical dendritic arborization was
etermined by Sholl analysis by measuring the total den-
ritic length and number of dendritic intersections within
ach concentric shell of 25 m radial distances extending
rom the cell body to the distal end of dendrites. Upon
xamination of the dendrites from proximal to distal re-
ions we saw significant increase in the total length of
endrites in the middle regions of the dendrites of neurons
rom layers 2/3 and layer 5 in CDP-choline-treated animals
Fig. 3B). However the apical dendrites of layer 2/3 neu-
ons in CDP-treated animals were more complex as seen
y the significant increase in branch order (Fig. 3C). The
otal number of branching points in the apical dendritic tree
Fig. 3D) is significantly more in layers 2/3 (P0.04) and
ayer 5 (P0.007). Sholl analysis also reflected a similar
ncrease in the number of intersections of dendritic
ranches (Fig. 3E) in layers 2/3 and 5.
ffect of CDP-choline on basal dendritic morphology
nalyses of basal dendritic morphology was done using
he same methods as those used to analyze the apical
endritic tree (Fig. 4). CDP-choline administration does not
ncrease the number of primary basal dendrites (Fig. 4A)
ut the total length of the basal dendrites is significantly
nhanced in neurons from layers 2/3 (P0.02), layer 4
P0.03) and layer 5 (P0.04) as shown in Fig. 4B. Fur-
her examination of dendritic length by Sholl analysis re-of control and CDP-choline administered rats. Note the increase in
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V. Rema et al. / Neuroscience 155 (2008) 556–564 559ealed that the total length of dendritic branches in each
uccessive 25 m concentric ring around the cell body
hroughout the entire dendritic tree is more in neurons of
DP-choline-treated animals (Fig. 4C). This increase was
ignificant in 50 m to 125 m radius from cell body of
ig. 3. Effect of CDP-choline on apical dendritic morphology. (A) Hist
nd 5. CDP-choline administration significantly increased sum total len
ll apical dendritic branches) of neurons in layers 2/3 and 5 of the som
f neurons from layers 2/3, 4 and 5 in 25 m concentric rings, from th
ncrease in length mainly in the middle section of the apical dendrites o
ats. (C) Branch order analyses of apical dendrites for neurons from
ranches order on neurons in layers 2/3. (D) Branch point analysis of
n number of nodes (branch points) in layers 2/3 and 5 suggests comp
E) Line graph showing the total number of intersections of apical den
sing Sholl ring analysis of neurons from different layers. Note the inc
igher complexity in branching pattern as compared with neurons in leurons from layers 2/3 and in 50 m to 75 m radius from Cell body of neurons from layer 4 and layer 5 of CDP-
holine-treated animals.
We estimated the complexity of branching by using
oth branch order analysis and by measuring the number
f branch points. As shown in Fig. 4D, administration of
owing the total length of apical dendrites for neurons in layers 2/3, 4
ical dendrites (which includes the total length of primary dendrite and
ry cortex. (B) Line graph illustrating the total length of apical dendrites
dy to the distal ends of dendrites, using Sholl ring analysis. Note the
in layer 2/3 and 5 from somatosensory cortex of CDP-choline-treated
nt cortical layers. CDP-choline treatment significantly increases the
ndrites for neurons from layers 2/3, 4 and 5. The significant increase
hing pattern in higher order branches in CDP-choline-treated animals.
5 m concentric rings, from cell body to distal ends of the dendrites,
apical dendritic intersections of neurons in layers 2/3 and 5 indicatingogram sh
gth of ap
atosenso
e cell bo
f neurons
differe
apical de
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rease inDP-choline significantly increased the of branch order on
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V. Rema et al. / Neuroscience 155 (2008) 556–564560asilar dendrites of neurons in the three layers within the
omatosensory cortex (P0.007 for layer 2/3; P0.002 for
ayer 4 and P0.005 for layer V). Increase in the number
f branch points on the basilar dendritic trees was also
bserved in CDP-choline-treated animals (P0.005 for
ayer 2/3; P0.005 for layer 4; P0.002 for layer 5). As an
dditional measure of complexity we examined the den-
ritic intersections with Sholl analysis in 25 m radial
istances extending from the cell body to distal ends of
ig. 4. Effect of CDP-choline on basal dendritic morphology. (A) Histo
of somatosensory cortex. CDP-choline administration does not incre
of somatosensory cortex. (B) Total length of basal dendrites of neuro
n total length of basal dendrites of neurons in layers 2/3, 4 and 5 of so
he length of basal dendrites of neurons in layers 2/3, 4 and 5 of somat
ncrease in dendritic length of neurons is in the proximal 50 m to 12
eurons in different layers of somatosensory cortex. Note the increase
reated rats. (E) Total number of branch point on basal dendrites of ne
ncreases number of branch points in neurons from layers 2/3, 4 a
ntersections of basal dendrites in 25 m concentric rings, from ce
omatosensory cortex. Neurons of layers 2/3, 4 and 5 from CDP-cholinasilar dendrites as shown in Fig. 4F. CDP-choline treat- 4ent increases the number of intersections of dendritic
ranches of all basal dendrites of neurons in all layers
long the entire dendritic tree.
Effect of CDP-choline on dendritic field. Measurement
f the total area occupied by the neuron was done using
onvex hull analysis. As shown in Fig. 5 CDP-choline
reatment increased the overall area occupied by the neu-
ons in supragranular layers 2/3 (P0.043), granular layer
owing total number of basal dendrites of neurons in layers 2/3, 4 and
number of primary basal dendrites of neurons from layers 2/3, 4 and
rs 2/3, 4 and 5 of somatosensory cortex. Note the significant increase
sory cortex in CDP-choline-treated animals. (C) Sholl ring analysis of
cortex from CDP-choline-treated and control rats. Note the significant
gion from cell body. (D) Branch order analysis of basal dendrites for
ranch order on the neurons from layers 2/3, 4 and 5 in CDP-choline-
different layers of somatosensory cortex. CDP-choline administration
somatosensory cortex. (F) Line graph showing the total number of
distal ends of dendrites, using Sholl ring analysis of neurons from
rats show higher dendritic intersections in proximal concentric shells.gram sh
ase the
ns in laye
matosen
osensory
5 m re
in the b
urons in
nd 5 of
ll body to(P0.046) and infragranular layer 5 (P0.053) of the
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V. Rema et al. / Neuroscience 155 (2008) 556–564 561omatosensory cortex indicating that the neurons in these
ayers have larger dendritic fields than controls.
Effect of CDP-choline on cell survival. Primary cul-
ures generated from the somatosensory cortex of normal
ong Evans P0 pups were treated with CDP-choline
50 M or 100 M) to determine its effect on survival of
ortical cells. To estimate the total number of cells in each
ondition the cultures were labeled with the nuclear stain
API and the total number of neurons was determined by
abeling the neurons with MAP2. CDP-choline treatment
id not have any effect on the total number of cells (Fig.
A) nor did it increase the number of neurons in both the
xperimental groups as compared with the controls (Fig.
B). Morphological details of traced neurons from the cul-
ures (Fig. 6C) were determined and analyzed using same
arameters as were used for in vivo analysis described
bove. The average number of neurites per neuron was
lso not different among all three groups (Fig. 6D). How-
ver similar to in vivo results, neurons in cultures treated
ith 100 M CDP-choline showed significantly longer neu-
ites (Fig. 6E) with more branch points (Fig. 6F) and occu-
ied a larger area (Fig. 6G).
DISCUSSION
e found that a daily dose of oral CDP-choline at 100 mg/
g/day during early development was sufficient to produce
ore dendritic branch points and longer dendrites on cor-
ical neurons. These changes occurred at doses shown to
ncrease dopamine release and dopamine dependent be-
avior in rats (Agut et al., 1984). Klein et al. (1990) have
hown that administration of CDP-choline at a dose of
00 mg/kg/day increases the plasma choline concentration
o 17 M, which is above the concentration (14 M) re-
uired to bring about net influx of choline into the brain.
ig. 5. Convex hull analysis of neurons from layers 2/3, 4 and 5
omatosensory cortex of control and CDP-choline administered rats.
DP-choline treatment increases the total dendritic field of neurons in
ayers 2/3, 4 and 5 of somatosensory cortex resulting in an increase in
he area occupied by the neurons.his increase in choline levels could facilitate synthesis of bembrane phosphatidylcholine and provide sufficient cho-
ine to up-regulate the synthesis of acetylcholine thereby
reventing degradation of membrane phosphatidylcholine
Adibhatla and Hatcher, 2005). These metabolic changes
ould be one of the possible mechanisms for the reduction
n neurologic deficits seen in CDP-choline-treated stroke
atients. Stroke also occurs during pregnancy (Mas and
amy, 1998; Sloan and Stern, 2003; Jaigobin and Silver,
000) and in young children (Nelson, 2007) and on the
asis of known beneficial effects CDP-choline could
merge as a treatment for these patients. However the
ffect on developing neurons following administration of
DP-choline either during pregnancy or at early perinatal
ges is unknown.
One of the goals of this study was to determine if
DP-choline administration during development of the ce-
ebral cortex affects neuronal morphology. Analyses of
MDAR1 expression in the developing rat somatosensory
ortex (Rema and Ebner, 1996) showed layer specific
odulation of NMDAR1 up to 60 days postnatal until the
table adult state is achieved. Hence we administered
DP-choline during gestation through 2 months postnatal.
he second goal of this investigation was to determine if
he changes induced by CDP-choline administration were
table. Long-term pharmacological intervention should be
voided if it is possible to achieve stable beneficial effect in
shorter time interval of drug administration. No study has
xamined the stability of morphological changes in neu-
ons following CDP-choline treatment. In this study we
herefore examined whether the effect of CDP-choline sup-
lement was stable over a relatively long time interval by
nalyzing the morphological changes after 6 months fol-
owing CDP-choline administration.
Our results show that CDP-choline administration
hrough gestation up to P60 enhances the dendritic mor-
hology of neurons in the somatosensory cortex for a very
ong period after discontinuing the drug. We analyzed the
endritic length and branch points on the dendrites, total
umber of basal dendrites and area occupied by the den-
ritic arbors of neurons from all layers of the somatosen-
ory cortex. Two major conclusions emerge from these
tudies: (i) CDP-choline administration during develop-
ent increases the surface area occupied by neurons in
he somatosensory cortex probably throughout life. There
s no reason to believe that these changes are restricted to
he area of cortex that we analyzed. (ii) The alterations in
he neuronal morphology were detected after a period of 6
onths following CDP-choline administration therefore we
redict that these changes are likely to be stable and
erhaps will persist even in aged rats. Such stability of
orphological changes could be the likely mechanism for
mprovement in memory in 24 month old rats seen by
respo et al. (2004) following oral administration of 150 mg
DP-choline per day for 12 months.
In a recent study Hurtado et al. (2007) observed that
he improvement of motor behavior in animals with unilat-
ral MCA occlusion following treatment with CDP-choline
s accompanied by significant increase in number of
ranches as well as spines on basal dendrites of pyramidal
n
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V. Rema et al. / Neuroscience 155 (2008) 556–564562eurons from layer 5 of motor cortex. However others have
hown that cortical injuries induce dendritic growth of layer
neurons in the contralateral hemisphere (Jones and
challert, 1994; Voorhies and Jones, 2002; Luke et al.,
004) and increase the number of spines (Adkins et al.,
002). It is therefore possible that the increase in dendritic
ranching and spines seen by Hurtado et al. (2007) in rats
ith MCA occlusion following i.p. injections of 1000 mg/kg
DP-choline treatment is influenced by the plastic
hanges resulting from injury to the brain in addition to the
ffect of CDP-choline on neuronal structure. Administering
arge doses of drug daily through the i.p. route over a long
ecovery period in humans might not be the best method
or long-term treatment. We therefore tested whether a
ower concentration of CDP-choline given by oral route for
elative short time is capable of producing stable changes
n neuronal morphology. In our study we found that
00 mg/kg of CDP-choline given as oral supplement was
ufficient to induce stable morphological changes in both
pical and basal dendrites of neurons in all layers of so-
atosensory cortex. However it is possible that a higher
oncentration is needed to produce similar changes after
njury or in the adult brain.
Clinical trials have been carried out to test the effec-
iveness of citicholine (CDP-choline) administration in pa-
ients with acute ischemic stroke using doses ranging from
00 mg to 2000 mg per day with varying results on the
ffectiveness of the drug (Cohen et al., 2003; Clark et al.,
999; Dávalos et al., 2002). The high dose of 2000 mg/
ay, compared with 500 mg/day, was shown to produce
ome degree of recovery of function in about 30% of
atients (Dávalos et al., 2002). The dosage of 100 mg/kg
e have used in this study depends on the weight of the rat
nd therefore is on the order of approximately two to four
imes higher than the dose of 2000 g/day given to a human
ubject. These results suggest that the degree of benefit
ay depend in some way on the concentration of
iticholine.
In the rat somatosensory cortex each layer is special-
zed in its input and output characteristics. We therefore
id layer-wise classification of our data and found that
DP-choline administration influences dendritic arboriza-
ion of pyramidal neurons in a layer specific manner. Neu-
ons in layers 2/3 and 5 showed significant changes in
ost morphological parameters analyzed. These layer
pecific influences could have important implications for
nformation processing within the somatosensory system.
eurons in layer 4 receive the major portion of sensory
nputs from the lemniscal pathway through the thalamus
nd in turn project to neurons of layers 2/3 (Kim and Ebner,
999; Petersen and Sakmann, 2001; Douglas and Martin,
ultures (which similar to in vivo results as shown in Fig. 4A). At higher
oncentration of CDP-choline (100 M) there is significant increase
E) in total length of neurites, (F) number of branch points and (G) area
ccupied by neurites. For all histograms hatched bar (labeled C)
epicts data from control cultures, gray bar (labeled 50) depicts dataig. 6. Effect of CDP-choline on survival and morphology of neurons
n culture. CDP-choline treatment (50 M or 100 M) of primary
ultures from somatosensory cortex does not increase survival of
A) the total number of cells, and (B) the total number of neurons. See
xperimental Procedures section for details of analysis. (C) Neurolu-
ida tracing of neurons from control and CDP-choline-treated cultures.
D) The number of primary neurites arising from the neurons is not rom cultures treated with 50 M CDP-choline and black bar (labeled
00) depicts data from cultures treated with 100 M CDP-choline.
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V. Rema et al. / Neuroscience 155 (2008) 556–564 563004; Shepherd and Svoboda, 2005). So it is possible that
he sensory information that arrives in the cortex is pro-
essed in a similar manner in both control and CDP-
holine-treated animals. But examination of the neuronal
rchitecture in the thalamic sensory nuclei is needed to
etermine if there are differences that could modify the
euronal activity of layer 4. However it is likely that there
ight be mechanisms preventing large-scale morphologi-
al changes in layer 4. Hints of layer 4 neurons’ stability
re also seen in other studies. For example sensory de-
rivation during early postnatal development does not af-
ect experience-dependent plasticity in layer 4 neurons of
dult rats whereas the neurons in layers 2/3 show signifi-
ant deficits (Rema et al., 2003). Also layer 4 neurons
how temporal delay in achieving experience-dependent
lasticity (Diamond et al., 1994).
Administration of CDP-choline during early develop-
ent could influence the survival of neurons and glia.
tudies that have examined the effect of CDP-choline on
urvival of neurons in disease conditions show contrasting
esults. In a Parkinson’s disease model Barrachina et al.
2003) showed attenuation of substantia nigra (SN) dopa-
inergic cell dropout suggesting that CDP-choline could
nfluence cell survival. CDP-choline at 100 M concentra-
ion has been shown to reduce cell death in an in vitro
odel of ischemia (Hurtado et al., 2005). However Sato
t al. (1988) did not observe a protective effect of CDP-
holine on cell survival in brains of rats with forebrain
schemia. Our results indicate that CDP-choline does not
ffect proliferation or survival of cells in culture (Fig. 6).
owever we saw an increase in both branching and length
f neurites in cultures treated with 100 M concentration of
DP-choline. This observation is similar to our in vivo
esults. Thus, these results indicate that one of the main
ffects of CDP-choline is to increase dendritic branching
round the neuron which in effect will increase the overall
onnectivity of neuron. It is possible that the effect of
DP-choline on the survival of neurons/cells in the brain is
ifferent from that seen in the cultures.
A key determinant of neuronal connectivity is dendritic
orphology. Neurons of layers 2/3 have extensive intra-
emispheric and interhemispheric cortical connections.
hey send axon collaterals to layer 5 of the same barrel
olumn and to several adjacent barrels. They also have
rajectories of projections to ipsilateral second somatosen-
ory cortex, dysgranular cortex and to contralateral barrel
ortex (Akers and Killackey, 1978; Olavarria et al., 1984;
hapin et al., 1987; Koralek et al., 1990; Fabri and Burton,
991; Kim and Ebner, 1999). Apical dendrites of layer 5
yramidal neurons project to layer 1 with branches that
amify in layers 2/3 and 4 (Schubert et al., 2001). Neurons
n layer 5 are also known to project to thalamic, pontine
nd brainstem sensory nuclei. Several studies show that
lasticity changes are more prominent in layers 2/3. In rats
obust changes in experience-dependent plasticity were
hown to occur first in layers 2/3 and in layer 5 (Diamond
t al., 1994). Restricted neonatal sensory deprivation re-
uced both responsiveness to sensory stimulation and
xperience-dependent plasticity in neurons of layers 2/3Rema et al., 2003) and disrupts receptive field structure
Shepherd et al., 2003). Integration of sensory information
hrough layer V neurons of the barrel cortex and cerebel-
um has been shown to be essential for whisker-guided
ensory behavior (Jenkinson and Glickstein, 2000). There-
ore our results showing a highly significant effect of CDP-
holine on dendritic field arborization of neurons in layers
/3 and 5 indicate that there is profound influence on
nformation processing which would bring about fast re-
ruitment of neurons within the network.
cknowledgments—This study was supported by the Wellcome
rust Senior Research Fellowship to V. Rema.
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